Skip to main content
. 2023 Aug 18;15(8):e43732. doi: 10.7759/cureus.43732

Table 1. Distribution of clinical data for the overall sample and stratified by the occurrence of prodromal symptoms.

A P-value of <0.05 was considered statistically significant. Data presented as N (%)

  Total (N) Prodromal symptoms P-value
Yes No
Total (N) 242 100 (41.3%) 142 (58.7%) -
Gender
Male 174 (71.9%) 64 (64%) 110 (77.5%) 0.014
Female 68 (28.1%) 36 (36%) 32 (22.5%)
Age        
<40 years 21 (8.7%) 10 (10%) 11 (7.7%) 0.446
41-60 years 157 (64.9%) 59 (59%) 98 (69%)
>60 years 64 (26.4%) 31 (31%) 33 (23.2%)
Married 239 (98.8%) 99 (99%) 140 (98.6%) 0.425
Employed 110 (45.5%) 37 (37%) 73 (51.4%) 0.009
Diagnose
ST-segment elevation myocardial infarction 179 (74%) 77 (77%) 102 (71.8%) 0.486
Non-ST-segment elevation myocardial infarction 63 (26%) 23 (23%) 40 (28.2%)
Medical history
Diabetes mellitus 66 (27.3%) 39 (39%) 27 (19%) 0.005
Hypertension 122 (50.4%) 45 (45%) 77 (54.2%) 0.171
Smoking 54 (22.3%) 15 (15%) 39 (27.5%) 0.086
Ischemic heart disease 38 (15.7%) 23 (23%) 15 (10.6%) <0.001